摘要
目的:研究PKM2在甲状腺乳头状癌(PTC)中的表达特性及其在PTC中的作用。方法:用抗PKM2的小干扰RNA转染PTC细胞。Western blot和RT-PCR技术分析细胞中PKM2的表达。MTT法和细胞平板克隆形成实验评估细胞的生长和增殖。采用乳酸、ATP和葡萄糖试剂盒分别测定细胞代谢产生的乳酸、ATP及消耗的葡萄糖。结果:PKM2在PTC中异常高表达。在PTC细胞系中应用特异性抗PKM2 siRNA可延缓细胞生长并降低其克隆形成能力。PKM2 siRNA可降低PTC细胞乳酸、ATP的产生,减少葡萄糖的消耗。结论:PKM2高表达可通过激活糖酵解的方式使PTC细胞具有选择性生长优势。PKM2异常高表达可能作为新的生物标记物,并成为PTC的潜在治疗靶点。
Objective:To investigate the expression pattern of PKM2 in papillary thyroid cancer(PTC) and the possible role of PKM2 in PTC.Methods:PTC cells were transfected with small interfering RNA against PKM2.PKM2 expression in cells was analyzed by Western blot and RT-PCR.Cell growth and proliferation was evaluated by MTT assays and colony formation assays.Lactate and ATP production and glucose consumption by cells were determined using commercial assay kits.Results:PKM2 was aberrantly overexpressed in PTC.Specific siRNA against PKM2 in PTC cell lines retarded cell growth and decreased their colony-forming capability.PKM2 knockdown also reduced lactate and ATP production,and glucose consumption by PTC cells.Conclusion:Overexpression of PKM2 provides a selective growth advantage for PTC cells through activation of glycolysis.Aberrant PKM2 overexpression may serve as a novel biomarker and a potential treatment target for PTC.
出处
《现代肿瘤医学》
CAS
2014年第2期278-282,共5页
Journal of Modern Oncology
基金
国家自然科学基金(编号:81200246)